Cargando…

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients

An increasing number of evidences have shown that the carcinogenic effect of DRAXIN plays an important role in the malignant process of tumors, but the mechanism of its involvement in glioma has not yet been revealed. The main aim of this study is to explore the relationship between DRAXIN and the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yulong, Liu, Zhendong, Cheng, Xingbo, Liu, Runze, Li, Pengxu, Kong, Defu, Liang, Wenjia, Liu, Binfeng, Wang, Hongbo, Bu, Xingyao, Gao, Yanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596576/ https://www.ncbi.nlm.nih.gov/pubmed/36040678 http://dx.doi.org/10.1007/s12031-022-02054-2

Ejemplares similares

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
por: Zhu, Qingyun, et al.
Publicado: (2023)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

Expression of Draxin in Lung Carcinomas
por: Sato, Younosuke, et al.
Publicado: (2018)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Novel function of the chemorepellent draxin as a regulator for hippocampal neurogenesis
por: Tawarayama, Hiroshi
Publicado: (2018)

Structural Basis for Draxin-Modulated Axon Guidance and Fasciculation by Netrin-1 through DCC
por: Liu, Ying, et al.
Publicado: (2018)

Draxin from neocortical neurons controls the guidance of thalamocortical projections into the neocortex
por: Shinmyo, Yohei, et al.
Publicado: (2015)

Olanzapine Increases Neural Chemorepulsant—Draxin Expression in the Adult Rat Hippocampus
por: Pałasz, Artur, et al.
Publicado: (2021)

Transcriptomic Identification of Draxin-Responsive Targets During Cranial Neural Crest EMT
por: Hutchins, Erica J., et al.
Publicado: (2021)

DRAXIN regulates interhemispheric fissure remodelling to influence the extent of corpus callosum formation
por: Morcom, Laura, et al.
Publicado: (2021)

A potential inhibitory function of draxin in regulating mouse trunk neural crest migration
por: Zhang, Sanbing, et al.
Publicado: (2016)

Draxin regulates hippocampal neurogenesis in the postnatal dentate gyrus by inhibiting DCC-induced apoptosis
por: Tawarayama, Hiroshi, et al.
Publicado: (2018)

Multiple Functions of Draxin/Netrin-1 Signaling in the Development of Neural Circuits in the Spinal Cord and the Brain
por: Ahmed, Giasuddin, et al.
Publicado: (2021)

Draxin acts as a molecular rheostat of canonical Wnt signaling to control cranial neural crest EMT
por: Hutchins, Erica J., et al.
Publicado: (2018)

Prognostic significance of HSF2BP in lung adenocarcinoma
por: Huang, Zhendong, et al.
Publicado: (2021)

High LAMC1 expression in glioma is associated with poor prognosis
por: Liu, Jian, et al.
Publicado: (2019)

The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients
por: Yao, Jiawei, et al.
Publicado: (2021)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
por: Zhang, Chunzhi, et al.
Publicado: (2012)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma
por: Tong, Yong-Qing, et al.
Publicado: (2015)

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma
por: Du, Shaonan, et al.
Publicado: (2020)

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
por: Tu, Yiming, et al.
Publicado: (2017)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_el470i2ddkduihfva1qnud5h4t